The AIS 2023 in France was a welcoming and familiar experience for us. Having participated in the previous year, we were able to expand our network and gain valuable insights into the challenges faced by the French biotech industry. Our presence at the conference allowed us to connect with loyal customers who regularly rely on our clinical-grade reference molecules for their research and drug development projects. Meeting these customers in person reinforced the strong relationships we have built in France.
We had the opportunity to explain our business model to conference participants, highlighting how our products and services align perfectly with their needs. The environment at AIS was ideal for showcasing the value we provide and fostering new partnerships.
Overall, the AIS 2023 provided a platform for us to meet friends, strengthen existing relationships, and connect with potential customers who truly appreciate our offerings. It was a rewarding experience that reaffirmed our position within the French biotech community.